A.I.Sure Pharmaceutical Private Limited, a active private limited company, was established on 24 April 2018 in Pune City, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U93090PN2018PTC176233. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.70 M and a paid-up capital of ₹2.67 M.
It upholds a compliant status. Employing 18 professional, Its leadership includes Sachin Vasanth Malawade (Director), Shanawaz Hashamali Kazi (Director), Mohammed Ayaz Sheikh (Director). Past directors included Fahim Mohammed, Sachin Vasanth Malawade, Shanawaz Hashamali Kazi. It holds ₹4.05 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Office No. 101, 1St Floor, Parmar Chambers,, S No. 4 B J Road, Near Sadhu Vaswani Chowk, Pune 411001, Pune City, Maharashtra, 411001.
U93090PN2018PTC176233
176233
24 April 2018
₹2.70 M
₹2.67 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into A.I.Sure Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sachin Vasanth Malawade | Director | 18 May 2021 | Current |
| Shanawaz Hashamali Kazi | Director | 01 Apr 2022 | Current |
| Mohammed Ayaz Sheikh | Director | 24 Apr 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 31 Jan 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
A.I.Sure Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.87% increase. The company also saw a slight improvement in profitability, with a 8.91% increase in profit. The company's net worth observed a substantial decline by a decrease of 124.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, A.I.Sure Pharmaceutical had a promoter holding of 56.25% and a public holding of 43.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,050,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2021 | Axis Bank Limited | ₹4.05 M | Open |
Explore comprehensive loan charge details -
A.I.Sure Pharmaceutical has a workforce of 18 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of A.I.Sure Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A.I.Sure Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A.I.Sure Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
A.I.Sure Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune. was recorded as a recent event.
Shanawaz Hashamali Kazi was appointed as a Director was appointed as a Director on 01 Apr 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 4.05 M with Charge ID 100450765 was registered on 08 Jun 2021. was documented.
The activity Sachin Vasanth Malawade was appointed as a Director was appointed as a Director on 18 May 2021 & has been associated with this company since 4 years 6 months . was completed.
The activity Mohammed Ayaz Sheikh was appointed as a Director was appointed as a Director on 24 Apr 2018 & has been associated with this company since 7 years 7 months . was completed.
The CIN of A.I.Sure Pharmaceutical Private Limited is U93090PN2018PTC176233.
A.I.Sure Pharmaceutical Private Limited is headquartered at Office No. 101, 1St Floor, Parmar Chambers,, S No. 4 B J Road, Near Sadhu Vaswani Chowk, Pune 411001, Pune City, Maharashtra, 411001.
A.I.Sure Pharmaceutical Private Limited was incorporated on 24 April 2018.
The current directors of A.I.Sure Pharmaceutical Private Limited are
The primary industry of A.I.Sure Pharmaceutical Private Limited is Manufacturing.
A.I.Sure Pharmaceutical Private Limited is unlisted.
The authorized capital of A.I.Sure Pharmaceutical Private Limited is ₹2.70 M, and the paid-up capital is ₹2.67 M.
The compliance status of A.I.Sure Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX